51N

5-O-[(R)-hydroxy(phosphonooxy)phosphoryl]-1-O-phosphono-alpha-D-ribofuranose

Created:	2015-06-15
Last modified:	2020-07-17

Find Related PDB Entry
1 entries where 51N is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	35
Chiral Atom Count	4
Bond Count	35
Aromatic Bond Count	0

2D diagram of 51N

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	5-O-[(R)-hydroxy(phosphonooxy)phosphoryl]-1-O-phosphono-alpha-D-ribofuranose
Synonyms	1'-ALPHA-PHOSPHORIBOSYL-5'-PYROPHOSPHORIC ACID; 5-O-[(R)-hydroxy(phosphonooxy)phosphoryl]-1-O-phosphono-alpha-D-ribose; 5-O-[(R)-hydroxy(phosphonooxy)phosphoryl]-1-O-phosphono-D-ribose; 5-O-[(R)-hydroxy(phosphonooxy)phosphoryl]-1-O-phosphono-ribose
Systematic Name (OpenEye OEToolkits)	[(2R,3S,4R,5R)-3,4-bis(oxidanyl)-5-phosphonooxy-oxolan-2-yl]methyl phosphono hydrogen phosphate
Formula	C₅ H₁₃ O₁₄ P₃
Molecular Weight	390.07
Type	D-SACCHARIDE

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	C1(OP(O)(O)=O)OC(C(C1O)O)COP(OP(O)(O)=O)(=O)O
SMILES	CACTVS	3.385	O[CH]1[CH](O)[CH](O[CH]1CO[P](O)(=O)O[P](O)(O)=O)O[P](O)(O)=O
SMILES	OpenEye OEToolkits	1.9.2	C(C1C(C(C(O1)OP(=O)(O)O)O)O)OP(=O)(O)OP(=O)(O)O
Canonical SMILES	CACTVS	3.385	O[C@H]1[C@@H](O)[C@H](O[C@@H]1CO[P](O)(=O)O[P](O)(O)=O)O[P](O)(O)=O
Canonical SMILES	OpenEye OEToolkits	1.9.2	C([C@@H]1[C@H]([C@H]([C@H](O1)OP(=O)(O)O)O)O)OP(=O)(O)OP(=O)(O)O
InChI	InChI	1.03	InChI=1S/C5H13O14P3/c6-3-2(1-16-22(14,15)19-21(11,12)13)17-5(4(3)7)18-20(8,9)10/h2-7H,1H2,(H,14,15)(H2,8,9,10)(H2,11,12,13)/t2-,3-,4-,5-/m1/s1
InChIKey	InChI	1.03	FPVTZUUYHCKWRL-TXICZTDVSA-N

Related Resource References

Resource Name	Reference
PubChem	121231450

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.